Cromoglicate, Related Therapy and Leukotriene Receptor Antagonists

Warning

Leukotriene Receptor Antagonists

Preferred list (P)

MONTELUKAST

  • Indicated for add–on therapy in mild to moderate persistent asthma, and to prevent exercise–induced bronchospasm.
  • Symptoms and peak expiratory flow should be monitored and treatment stopped if there is no demonstrable benefit within 3 months.

NHSL Joint Adult Formulary Key

To indicate the category of a formulary medicine, updated sections adopt the following key:

Preferred list (P): First-line formulary choices.

Total list (T): Alternative choices when preferred list options not effective/not tolerated, or not indicated.

Specialist initiation (S1): Specialist initiation, or on the advice of a Consultant or Specialist Practitioner in this therapeutic area. Continuation in primary care is acceptable.

Specialist use only (S2): Supply via hospital, Homecare Service or a hospital based prescription (HBP) for dispensing by community pharmacy. Not prescribed in primary care setting.

Editorial Information

Last reviewed: 31/01/2022

Next review date: 31/01/2025

Author(s): NHSL.

Version: Please refer to the introduction section for an explanation of the review dates above.

Approved By: ADTC

Reviewer name(s): ADTC.